Suppr超能文献

慢性乙型肝炎自然史分期标准的现存问题与新建议

Existing problems and new advice on stage criteria of natural history for chronic hepatitis B.

作者信息

Xing Tongjing

机构信息

Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Linhai, Zhejiang Province, China.

出版信息

BMC Infect Dis. 2025 Jan 3;25(1):17. doi: 10.1186/s12879-024-10408-x.

Abstract

The natural stages of chronic hepatitis B can be divided into four stages according to changes in virology, biochemistry, and pathology. However, there have been significant differences in the recommended stage criteria in the several major guidelines for chronic hepatitis B, especially regarding the immune tolerance phase. Inconsistent standards of indicators for different stages resulted in some problems, such as incorrect stage, uncertain stages and poor comparation of related studies. We propose suggestions for revisions to the stage criteria for CHB based on recent researches, including three stages: immune tolerance stage, immune clearance stage, and immune control stage. These revision suggestions rationalize some of the existing problems with the stage criteria for CHB and can significantly reduce the number of patients in the "uncertain stage" or "gray zone," which is particularly valuable in guiding clinical practice. However, further clinical studies with large samples are needed to confirm these suggestions.

摘要

慢性乙型肝炎的自然病程根据病毒学、生物化学及病理学变化可分为四个阶段。然而,在几部主要的慢性乙型肝炎指南中,推荐的分期标准存在显著差异,尤其是在免疫耐受期方面。不同阶段指标标准不一致导致了一些问题,如分期错误、分期不明确以及相关研究可比性差等。我们基于近期研究对慢性乙型肝炎的分期标准提出修订建议,包括三个阶段:免疫耐受期、免疫清除期和免疫控制期。这些修订建议使慢性乙型肝炎分期标准中存在的一些问题更加合理,并且能显著减少处于“分期不明确阶段”或“灰色地带”的患者数量,这对于指导临床实践尤为重要。然而,需要进一步开展大样本临床研究以证实这些建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee03/11699759/fafc716f4632/12879_2024_10408_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验